US Stock MarketDetailed Quotes
EVFM Evofem Biosciences
Watchlist
0.070
0.0000.00% Close 12/06 16:00 ET
0.083High0.061Low204.90KVolume
0.061Open0.070Pre Close14.52KTurnover1.91%Turnover Ratio0.00P/E (TTM)751.11KMarket Cap10.36352wk High0.00P/E (Static)10.73MShares0.05552wk Low-0.01P/B751.00KFloat Cap23550.000Historical High--Dividend TTM10.73MShs Float0.055Historical Low--Div YieldTTM31.74%Amplitude0.070Avg Price1Lot Size
About Evofem Biosciences Company
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
Company Profile
SymbolEVFM
Company NameEvofem Biosciences
Listing Date11/20/2014
Issue Price14.00
Founded2007
CEOMs. Saundra Pelletier
MarketPink Market
Employees37
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7770 Regents Road,Suite 113-618
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92122
Phone1-858-550-1900
Websitehttp://www.evofem.com
Company Executives
- Name
- Position
- Salary
- Saundra Pelletier
- Interim Chairman of the Board, President and Chief Executive Officer
- 3.19M
- Justin J. File
- Chief Financial Officer and Principal Accounting Officer
- 1.26M
- Alexander A. Fitzpatrick, Esq.
- General Counsel and Secretary
- 1.05M
- Colin Rutherford
- Independent Director
- 158.23K
- Dr. Kim P. Kamdar
- Independent Director
- 159.48K
- Dr. Gillian Greer, PhD
- Independent Director
- 150.73K
- Tony O’Brien
- Independent Director
- 163.23K
- Dr. Lisa Dale Rarick, F.A.C.O.G.
- Independent Director
- 140.35K
- Jenny Yip
- Independent Director
- --